A preliminary review of side effects from popular drugs used to treat diabetes and obesity shows no link with suicidal thoughts or actions, the U.S. Food and Drug Administration said Thursday.

But the agency also said officials cannot definitively rule out that “a small risk may exist” and that they’ll continue to look into reports regarding more than a dozen drugs, including Ozempic, Wegovy and Mounjaro. Patients taking the drugs should report any concerns to health care providers, the FDA said.

The review follows a recent federally funded study that showed that people taking semaglutide, the medication in Ozempic and Wegovy, had a lower risk of suicidal thoughts than those taking other drugs to treat obesity and diabetes.

“Our preliminary evaluation has not found evidence that use of these medicines causes suicidal thoughts or actions,” the FDA report said.

Feds investigating Boeing after midair blow out

The Federal Aviation Administration is investigating whether Boeing failed to make sure a panel that blew off a jetliner in midflight last week was safe and manufactured to meet the design that regulators approved.

The FAA investigation announced Thursday is focusing on plugs used to fill spots for extra exits when those doors are not required on Boeing 737 Max 9 jetliners.

Boeing said it would cooperate with the investigation and one being conducted by the National Transportation Safety Board.

The 63-pound door plug that blew off an Alaska Airlines Max 9 was found near Portland, Oregon, and will be be examined in the NTSB’s laboratory.

“This incident should have never happened and it cannot happen again,” the FAA said in a statement. “Boeing’s manufacturing practices need to comply with the high safety standards they’re legally accountable to meet.”